Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia

Affiliations

• ¹ Hematology, Department of Medicine and Surgery, University of Insubria, Ospedale di Circolo, ASST Sette Laghi, Varese, Italy.
• ² Biophysics Institute, National Research Council of Italy, c/o Department of Biosciences, University of Milan, via Celoria 26, I-20133 Milan, Italy.
• ³ CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Department of Experimental and Clinical Medicine, Azienda ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy.
• ⁴ Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy.
• ⁵ University of Milan, Hematology and BMT Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
• ⁶ Ospedale Niguarda Cà Granda, Milano, Italy.
• ⁷ Moffit Cancer Center, Tampa, FL, United States.
• ⁸ Stanford University, Palo Alto, CA, United States.
• ⁹ Hôpital Saint-Louis et Université Paris Diderot, Paris, France.
• ¹⁰ Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
• ¹¹ Department of Hematology, University Hospitals Leuven and Laboratory of Experimental Transplantation, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
• ¹² Policlinico S. Orsola-Malpighi, Bologna, Italy.
• ¹³ Università Cattolica del Sacro Cuore, Roma, Italy.
• ¹⁴ Ospedale S. Bortolo, Vicenza, Italy.
• ¹⁵ Weill Cornell Medical College, New York, United States.
• ¹⁶ Centro Oncologico Ematologico Subalpino (COES), Torino, Italy.
• ¹⁷ Università di Bari, Bari, Italy.
• ¹⁸ FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy.
• ¹⁹ Hematology, Department of Medicine and Surgery, University of Insubria, Ospedale di Circolo, ASST Sette Laghi, Varese, Italy. Electronic address: francesco.passamonti@uninsubria.it.